Northwire Canada EditionSunday, July 12, 2026
Northwire
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%
Other Routine +

CHARBONE annonce la signature d'un contrat d'approvisionnement de trois ans en oxygene UHP avec un client strategique americain, renforcant sa presence aux Etats-Unis

Charbone Secures US Oxygen Contract as Multi-Molecule Strategy Gains Traction Amidst Dilution Concerns

Executive Summary
  • Date: April 23, 2026
  • Event: Signing of a three-year supply agreement for Ultra High Purity (UHP) oxygen with a strategic American client.
  • Location: United States, specifically the "Tech Valley" region of New York State.
  • Strategic Context: This contract is part of Charbone's broader "multi-molecule" strategy unveiled in April 2026 to expand beyond hydrogen into oxygen, helium, and specialty gases.
  • Validation: The agreement follows previous orders and initial deliveries of UHP oxygen to this client, confirming commercial repeatability in the US market.
  • Management Quote: CEO Dave B. Gagnon stated the contract validates their ability to deliver high-purity gases according to demanding standards and strengthens their North American presence.
Material Impact
  • Incremental Validation: The news confirms execution of the strategic plan announced on April 14, 2026 (Transformation towards an integrated industrial gas group). It is not a new surprise but rather proof of concept for the multi-molecule pivot.
  • Revenue Stability: A three-year term provides more visibility than spot sales, supporting recurring revenue goals outlined in Pillar B of their strategy.
  • Market Expectations: The market has already priced in US expansion following the January 2026 first US hydrogen order and February 2026 first oxygen order announcements. This release closes the loop on those initial orders with a formal contract.
  • Price Impact: Likely neutral to slightly positive short-term, as the stock has been trending downward from December highs ($0.36) to current levels ($0.14). The news does not address the significant dilution or debt concerns that have likely suppressed the price recently.
CH · Price
Company Overview
  • Core Business: Production and distribution of Ultra High Purity (UHP) industrial gases, primarily hydrogen, expanding to oxygen and helium.
  • Flagship Project: Sorel-Tracy Hydrogen Plant in Quebec. Phase 1A is operational; Phase 1B aims to increase capacity to ~1 tonne/day.
  • Strategy: Transition from a single-molecule producer (Hydrogen) to an integrated industrial gas group using a "hub-and-spoke" model across North America and Asia-Pacific.
  • Operations: Modular production approach allows for decentralized deployment in key tech corridors (Ontario, NY Tech Valley, Malaysia).
Read the original news release →

More from Charbone Hydrogen Corporation